name: FacileTCGADataSet
organism: Homo sapiens
default_assay: rnaseq
datasets:
  BLCA:
    url: https://portal.gdc.cancer.gov/projects/TCGA-BLCA
    description: Bladder urothelial carcinoma
  BRCA:
    url: https://portal.gdc.cancer.gov/projects/TCGA-BRCA
    description: Breast invasive carcinoma
sample_covariates:
  stage:
    varname: stage
    type: clinical
    class: categorical
    levels: ["stage i", "stage ii", "stage iii", "stage iv"]
    description: Cancer staging classification (I-IV)
    label: Pathological Tumor Staging
  sex:
    varname: sex
    type: clinical
    class: categorical
    levels: ['male', 'female'] # reversed factor
    description: "chrX:chrY ratio"
    label: Sex
  age:
    varname: age
    type: clinical
    class: real
    description: Age of patient in years
    label: Age (years)
  subtype_molecular_bladder:
    varname: subtype_molecular_bladder
    type: tumor_classification
    class: categorical
    # levels: ["luminal", "basal"] # for test, we don't specify this is factor
    description: >
      The luminal/basal subtyping scheme in bladder, as defined by Damrauer et al.
      (doi:10.1073/pnas.1318376111). For a larger umbrella review
      of the diversity of bladder subtypes, you can refer to doi:10.1038/nrc3817.
    label: Bladder cancer subtype (luminal/basal)
  subtype_receptor_breast:
    varname: subtype_receptor_breast
    type: tumor_classification
    class: categorical
    levels: ["ER+/PR+", "Her2+", "TNBC"]
    description: >
      Breast cancer classification based on amplification and/or deletion of
      different receptors.
    label: Breast cancer subtype (receptor status)
  sample_type:
    varname: sample_type
    type: clinical
    class: categorical
    levels: ['normal', 'tumor', 'tumor_metastatic']
    description: Whether sample comes from a tumor or adjacent normal
    label: Sample type (tumor/normal)


